Establishment Labs Holdings Inc. (ESTA) News
Filter ESTA News Items
ESTA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ESTA News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest ESTA News From Around the Web
Below are the latest news stories about ESTABLISHMENT LABS HOLDINGS INC that investors may wish to consider to help them evaluate ESTA as an investment opportunity.
Establishment Labs Holdings (NASDAQ:ESTA) shareholders have earned a 12% CAGR over the last five yearsWhen you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than... |
Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNEW YORK, January 07, 2025--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 3:45 p.m. Pacific Time. |
Why Is Establishment Labs Holdings Inc. (ESTA) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are going to take a look at where Establishment Labs Holdings Inc. (NASDAQ:ESTA) stands against the other cosmetic surgery and aesthetics stocks. In the face of economic uncertainty, consumer preferences in the beauty industry […] |
3 US Stocks Trading At An Estimated 16.4% To 35.6% Below Intrinsic ValueAs the U.S. market continues to show resilience with major indices like the Dow Jones and S&P 500 on track for a winning month, investors are keenly observing how these trends impact stock valuations. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can be a strategic move for those looking to capitalize on potential market inefficiencies. |
Some Establishment Labs Holdings Inc. (NASDAQ:ESTA) Analysts Just Made A Major Cut To Next Year's EstimatesMarket forces rained on the parade of Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) shareholders today, when the... |
Establishment Labs Announces Participation in Upcoming Investment ConferencesNEW YORK, November 11, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in three upcoming investment conferences. |
Establishment Labs Holdings Third Quarter 2024 Earnings: EPS Beats ExpectationsEstablishment Labs Holdings ( NASDAQ:ESTA ) Third Quarter 2024 Results Key Financial Results Revenue: US$40.2m (up 4.5... |
Establishment Labs price target lowered to $62 from $65 at BTIGBTIG lowered the firm’s price target on Establishment Labs (ESTA) to $62 from $65 and keeps a Buy rating on the shares after its Q3 results. The company’s U.S. Motiva launch is exceeding the bullish forecasts, though its LatAm market continues to face challenges, most notably in Brazil, where procedure volumes in certain regions declined as much as a 50% y/y, the analyst tells investors in a research note. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina |
Establishment Labs Holdings Inc (ESTA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...Establishment Labs Holdings Inc (ESTA) reports a 4.5% revenue increase and outlines promising U.S. market strategies amid global challenges. |
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Misses Revenue EstimatesEstablishment Labs (ESTA) delivered earnings and revenue surprises of 3.28% and 0.92%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? |